Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LNT✓SelectedUSD · LNTGSK vs LNT performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs LNT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+102.1%
LNT return
+176.1%
Excess return
-74.0%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioLNTExcessAlpha
1D-1.3%+1.1%-2.4%-1.7%
7D-3.1%-2.1%-1.0%-2.4%
30D-0.9%+8.6%-9.5%-3.8%
3M-4.2%+3.8%-8.0%-5.5%
6M-1.6%+1.5%-3.1%-2.2%
YTD+2.6%+14.3%-11.7%-2.5%
1Y+6.2%+9.2%-2.9%+2.7%
3Y+55.0%+61.7%-6.7%+29.2%
5Y+42.8%+53.6%-10.8%+19.4%
10Y+102.1%+176.9%-74.8%+42.8%
All+102.1%+176.1%-74.0%+42.8%

Cumulative growth

Daily Returns

Daily percentage return beside LNT.

Daily Out/Under-Performance

Portfolio return minus LNT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LNT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded LNT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling